• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovartis

Novartis

Page 4 of 5
Close up of surgical tools and money
Health
Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By Sy MukherjeeJuly 15, 2016
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health
Why Shares of Next-Gen Cancer Biotech Juno Rallied Today
By Sy MukherjeeJuly 13, 2016
Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
Health
Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
By Sy MukherjeeJune 27, 2016
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
Health
This Is the Most Important Business Trend in Pharma
By Sy MukherjeeJune 21, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
These Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
The Sad and Inspiring Reason This Top Novartis Exec Stepped Down
MPW
The Sad and Inspiring Reason This Top Novartis Exec Stepped Down
By Eileen DaspinMay 31, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health
Struggling Novartis Heart Drug Boosted by New Medical Guidelines
By ReutersMay 21, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health
Novartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
Venezuela Tense As Unrest Over President Maduro's Government Continues
Venezuela Is Using Distressed Bonds to Pay Off Its Debts to Drugmakers
By ReutersMarch 7, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Finance
Novartis Agrees to $390 Million Settlement
By Jen WiecznerNovember 20, 2015
Parkinson’s patients show improvement after taking cancer drug
Health
Parkinson’s patients show improvement after taking cancer drug
By Claire ZillmanOctober 19, 2015
France's Gevrise Emane (L) celebrates he
Leadership
40 Under 40: Advice I’d give my 20-year-old self
By Daniel RobertsSeptember 25, 2015
40 Under 40: The lowest moment in my career
Leadership
40 Under 40: The lowest moment in my career
By Jonathan ChewSeptember 25, 2015
Novartis’s pathway to business longevity
Features
Novartis’s pathway to business longevity
By Geoff ColvinMarch 21, 2013
1
  • 1
  • 2
  • 3
  • 4
  • 5
5
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.